Original Research

Published on 25 Jul 2024

mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies

in Vaccines and Molecular Therapeutics

Javier Guenaga
Mehrdad Alirezaei
Yu Feng
Mohamad-Gabriel Alameh
Wen-Hsin Lee
Sabyasachi Baboo
Jocelyn Cluff
Richard Wilson
Shridhar Bale
Gabriel Ozorowski

Frontiers in Immunology

doi 10.3389/fimmu.2024.1426232

2,686 views

Original Research

Published on 24 Jul 2024

Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins

in Vaccines and Molecular Therapeutics

Karen J. Gonzalez
Kevin C. Yim
Jorge C. G. Blanco
Marina S. Boukhvalova
Eva-Maria Strauch

Frontiers in Immunology

doi 10.3389/fimmu.2024.1406929

2,073 views

Review

Published on 23 Jul 2024

From pathogenesis to antigens: the key to shaping the future of TB vaccines

in Vaccines and Molecular Therapeutics

Haoyan Yang
Xinkui Lei
Siyu Chai
Guimin Su
Lin Du

Frontiers in Immunology

doi 10.3389/fimmu.2024.1440935

1,651 views

Original Research

Published on 23 Jul 2024

Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitization

in Vaccines and Molecular Therapeutics

Konner J. Jackson
Cassandra Buhl
Shannon M. Miller
Juhienah K. Khalaf
Janine Ward
Cherrokee Sands
Lois Walsh
Margaret Whitacre
David J. Burkhart
Hélène G. Bazin-Lee

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421758

1,643 views

Brief Research Report

Published on 19 Jul 2024

A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants

in Vaccines and Molecular Therapeutics

Sergey V. Guselnikov
Konstantin O. Baranov
Sergey V. Kulemzin
Tatyana N. Belovezhets
Anton N. Chikaev
Svetlana V. Murasheva
Olga Y. Volkova
Ludmila V. Mechetina
Alexander M. Najakshin
Nikolai A. Chikaev

Frontiers in Immunology

doi 10.3389/fimmu.2024.1442160

1,151 views

Review

Published on 16 Jul 2024

Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?

in Vaccines and Molecular Therapeutics

Srdan Tadic
Alfredo Martínez

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433185

2,595 views

Original Research

Published on 16 Jul 2024

A nanoparticle vaccine displaying varicella-zoster virus gE antigen induces a superior cellular immune response than a licensed vaccine in mice and non-human primates

in Vaccines and Molecular Therapeutics

Yuanyuan Li
Siyu Tian
Yuanbao Ai
Zhulong Hu
Chao Ma
Meijuan Fu
Zhenqian Xu
Yan Li
Shuyun Liu
Yongjuan Zou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419634

2,431 views

Original Research

Published on 16 Jul 2024

A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus

in Vaccines and Molecular Therapeutics

Tony W. Ng
Wakako Furuyama
Ariel S. Wirchnianski
Noemí A. Saavedra-Ávila
Christopher T. Johndrow
Kartik Chandran
William R. Jacobs
Andrea Marzi
Steven A. Porcelli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429909

1,886 views

Brief Research Report

Published on 16 Jul 2024

The seroconversion history to SARS-CoV-2 in Indigenous people from Brazil – the interplay between exposure, vaccination, and tuberculosis

in Vaccines and Molecular Therapeutics

Alice Nagai
Renan Barbosa Lemes
José Geraldo Mill
Alexandre Costa Pereira
Rafael Elias Marques
Tábita Hünemeier

Frontiers in Immunology

doi 10.3389/fimmu.2024.1359066

1,543 views

Original Research

Published on 15 Jul 2024

Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination

in Vaccines and Molecular Therapeutics

Valeria Orrù
Valentina Serra
Michele Marongiu
Sandra Lai
Valeria Lodde
Magdalena Zoledziewska
Maristella Steri
Annalisa Loizedda
Monia Lobina
Maria Grazia Piras

Frontiers in Immunology

doi 10.3389/fimmu.2024.1416464

1,593 views
1 citation

Original Research

Published on 12 Jul 2024

Identifying transcriptomic profiles in ovine spleen after repetitive vaccination

in Vaccines and Molecular Therapeutics

Aitor Guisasola-Serrano
Martin Bilbao-Arribas
Endika Varela-Martínez
Naiara Abendaño
Marta Pérez
Lluís Luján
Begoña Marina Jugo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1386590

892 views

Editorial

Published on 11 Jul 2024

Editorial: Vaccine-induced innate immunity and its role in viral infections

in Vaccines and Molecular Therapeutics

Mohammad Arif Rahman
Tesfaye Gelanew
Soumik Barman
Firzan Nainu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1440061

1,074 views

Original Research

Published on 10 Jul 2024

Development of a subunit vaccine against the cholangiocarcinoma causing Opisthorchis viverrini: a computational approach

in Vaccines and Molecular Therapeutics

Mohibullah Shah
Farva Sitara
Asifa Sarfraz
Muhammad Shehroz
Tehreem Ul Wara
Asia Perveen
Najeeb Ullah
Aqal Zaman
Umar Nishan
Sarfraz Ahmed

Frontiers in Immunology

doi 10.3389/fimmu.2024.1281544

3,154 views
2 citations

Original Research

Published on 10 Jul 2024

Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2

in Vaccines and Molecular Therapeutics

Hongwei Liu
Terza Brostoff
Ana Ramirez
Talia Wong
Douglas J. Rowland
Mollie Heffner
Arturo Flores
Brandon Willis
Jeffrey J. Evans
Louise Lanoue

Frontiers in Immunology

doi 10.3389/fimmu.2024.1428711

1,262 views

Original Research

Published on 08 Jul 2024

Timing of maternal vaccination against COVID-19 for effective protection of neonates: cohort study

in Vaccines and Molecular Therapeutics

Aleksandra Nowakowska
Seung Mi Lee
Minjee Kim
Jungmin Chun
Sehyun Kim
Byung Chul Kim
Hyun Ju In
Eunji Lee
Chanyeong Lee
Hyeondong Lee

Frontiers in Immunology

doi 10.3389/fimmu.2024.1359209

1,120 views

Original Research

Published on 08 Jul 2024

Immunomodulatory effect of PLGA-encapsulated mesenchymal stem cells-derived exosomes for the treatment of allergic rhinitis

in Vaccines and Molecular Therapeutics

Khawar Ali Shahzad
Zhao Wang
Xuran Li
Jiaojiao Li
Maoxiang Xu
Fei Tan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429442

2,702 views
2 citations

Navigation group

Articles

mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies

Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins

From pathogenesis to antigens: the key to shaping the future of TB vaccines

Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitization

A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants

Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?

A nanoparticle vaccine displaying varicella-zoster virus gE antigen induces a superior cellular immune response than a licensed vaccine in mice and non-human primates

A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus

The seroconversion history to SARS-CoV-2 in Indigenous people from Brazil – the interplay between exposure, vaccination, and tuberculosis

Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination

Identifying transcriptomic profiles in ovine spleen after repetitive vaccination

Editorial: Vaccine-induced innate immunity and its role in viral infections

Development of a subunit vaccine against the cholangiocarcinoma causing Opisthorchis viverrini: a computational approach

Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2

Timing of maternal vaccination against COVID-19 for effective protection of neonates: cohort study

Immunomodulatory effect of PLGA-encapsulated mesenchymal stem cells-derived exosomes for the treatment of allergic rhinitis